273 related articles for article (PubMed ID: 24310226)
1. Interleukin 17 contributes to the chronicity of inflammatory diseases such as rheumatoid arthritis.
Benedetti G; Miossec P
Eur J Immunol; 2014 Feb; 44(2):339-47. PubMed ID: 24310226
[TBL] [Abstract][Full Text] [Related]
2. IL-27-producing CD14(+) cells infiltrate inflamed joints of rheumatoid arthritis and regulate inflammation and chemotactic migration.
Tanida S; Yoshitomi H; Ishikawa M; Kasahara T; Murata K; Shibuya H; Ito H; Nakamura T
Cytokine; 2011 Aug; 55(2):237-44. PubMed ID: 21592822
[TBL] [Abstract][Full Text] [Related]
3. IL-26 is overexpressed in rheumatoid arthritis and induces proinflammatory cytokine production and Th17 cell generation.
Corvaisier M; Delneste Y; Jeanvoine H; Preisser L; Blanchard S; Garo E; Hoppe E; Barré B; Audran M; Bouvard B; Saint-André JP; Jeannin P
PLoS Biol; 2012; 10(9):e1001395. PubMed ID: 23055831
[TBL] [Abstract][Full Text] [Related]
4. IL-37 Alleviates Rheumatoid Arthritis by Suppressing IL-17 and IL-17-Triggering Cytokine Production and Limiting Th17 Cell Proliferation.
Ye L; Jiang B; Deng J; Du J; Xiong W; Guan Y; Wen Z; Huang K; Huang Z
J Immunol; 2015 Jun; 194(11):5110-9. PubMed ID: 25917106
[TBL] [Abstract][Full Text] [Related]
5. The Th17 pathway as a therapeutic target in rheumatoid arthritis and other autoimmune and inflammatory disorders.
Roeleveld DM; van Nieuwenhuijze AE; van den Berg WB; Koenders MI
BioDrugs; 2013 Oct; 27(5):439-52. PubMed ID: 23620106
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow-derived and synovium-derived mesenchymal cells promote Th17 cell expansion and activation through caspase 1 activation: contribution to the chronicity of rheumatoid arthritis.
Eljaafari A; Tartelin ML; Aissaoui H; Chevrel G; Osta B; Lavocat F; Miossec P
Arthritis Rheum; 2012 Jul; 64(7):2147-57. PubMed ID: 22275154
[TBL] [Abstract][Full Text] [Related]
7. IL-17/Th17 mediated synovial inflammation is IL-22 independent.
van Hamburg JP; Corneth OB; Paulissen SM; Davelaar N; Asmawidjaja PS; Mus AM; Lubberts E
Ann Rheum Dis; 2013 Oct; 72(10):1700-7. PubMed ID: 23328939
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-15 induces interleukin-17 production by synovial T cell lines from patients with rheumatoid arthritis.
Halvorsen EH; Strønen E; Hammer HB; Goll GL; Sollid LM; Molberg O
Scand J Immunol; 2011 Mar; 73(3):243-9. PubMed ID: 21204897
[TBL] [Abstract][Full Text] [Related]
9. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
10. Effects of interleukin (IL)-17A and IL-17F in human rheumatoid arthritis synoviocytes.
Hot A; Miossec P
Ann Rheum Dis; 2011 May; 70(5):727-32. PubMed ID: 21345813
[TBL] [Abstract][Full Text] [Related]
11. Complementary action of granulocyte macrophage colony-stimulating factor and interleukin-17A induces interleukin-23, receptor activator of nuclear factor-κB ligand, and matrix metalloproteinases and drives bone and cartilage pathology in experimental arthritis: rationale for combination therapy in rheumatoid arthritis.
van Nieuwenhuijze AE; van de Loo FA; Walgreen B; Bennink M; Helsen M; van den Bersselaar L; Wicks IP; van den Berg WB; Koenders MI
Arthritis Res Ther; 2015 Jun; 17(1):163. PubMed ID: 26081345
[TBL] [Abstract][Full Text] [Related]
12. TNF blockade requires 1,25(OH)2D3 to control human Th17-mediated synovial inflammation.
van Hamburg JP; Asmawidjaja PS; Davelaar N; Mus AM; Cornelissen F; van Leeuwen JP; Hazes JM; Dolhain RJ; Bakx PA; Colin EM; Lubberts E
Ann Rheum Dis; 2012 Apr; 71(4):606-12. PubMed ID: 22219138
[TBL] [Abstract][Full Text] [Related]
13. The role of the Th17 cytokines IL-17 and IL-22 in Rheumatoid Arthritis pathogenesis and developments in cytokine immunotherapy.
Roeleveld DM; Koenders MI
Cytokine; 2015 Jul; 74(1):101-7. PubMed ID: 25466295
[TBL] [Abstract][Full Text] [Related]
14. Th17 Cells in Immunopathogenesis and treatment of rheumatoid arthritis.
Azizi G; Jadidi-Niaragh F; Mirshafiey A
Int J Rheum Dis; 2013 Jun; 16(3):243-53. PubMed ID: 23981743
[TBL] [Abstract][Full Text] [Related]
15. Rheumatoid arthritis bone marrow environment supports Th17 response.
Kuca-Warnawin E; Kurowska W; Prochorec-Sobieszek M; Radzikowska A; Burakowski T; Skalska U; Massalska M; Plebańczyk M; Małdyk-Nowakowska B; Słowińska I; Gasik R; Maśliński W
Arthritis Res Ther; 2017 Dec; 19(1):274. PubMed ID: 29216915
[TBL] [Abstract][Full Text] [Related]
16. IL-17 increases cadherin-11 expression in a model of autoimmune experimental arthritis and in rheumatoid arthritis.
Park YE; Woo YJ; Park SH; Moon YM; Oh HJ; Kim JI; Jin HS; Baek SH; Kim GT; Lee JH; Cho ML; Kim SI
Immunol Lett; 2011 Oct; 140(1-2):97-103. PubMed ID: 21798287
[TBL] [Abstract][Full Text] [Related]
17. Contribution of interleukin 17 to synovium matrix destruction in rheumatoid arthritis.
Chabaud M; Garnero P; Dayer JM; Guerne PA; Fossiez F; Miossec P
Cytokine; 2000 Jul; 12(7):1092-9. PubMed ID: 10880256
[TBL] [Abstract][Full Text] [Related]
18. Functional niche of inflamed synovium for Th17-cell expansion and activation in rheumatoid arthritis: implication to clinical therapeutics.
Dong W; Zhu P
Autoimmun Rev; 2012 Oct; 11(12):844-51. PubMed ID: 22406293
[TBL] [Abstract][Full Text] [Related]
19. Interleukin (IL)-23 p19 expression induced by IL-1beta in human fibroblast-like synoviocytes with rheumatoid arthritis via active nuclear factor-kappaB and AP-1 dependent pathway.
Liu FL; Chen CH; Chu SJ; Chen JH; Lai JH; Sytwu HK; Chang DM
Rheumatology (Oxford); 2007 Aug; 46(8):1266-73. PubMed ID: 17569750
[TBL] [Abstract][Full Text] [Related]
20. Osteoclasts in arthritis and Th17 cell development.
Okamoto K; Takayanagi H
Int Immunopharmacol; 2011 May; 11(5):543-8. PubMed ID: 21081190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]